LAURMEDIUM SIGNALOPPORTUNITY10-K

Laureate Education expanded meaningfully across key metrics with 19.5% revenue growth, substantial enrollment increases to 497,700 students, and strengthened cash generation.

The company demonstrated solid operational momentum with enrollment growing from 472,000 to 497,700 students while expanding its medical school footprint from 23 to 24 institutions. The combination of revenue growth, improved operating leverage, and substantially higher operating cash flow suggests the business is successfully scaling its educational platform across Mexico and Peru.

Comparing 2026-02-19 vs 2025-02-20View on EDGAR →
FINANCIAL ANALYSIS

Laureate showed broad-based financial strengthening with revenue growing 19.5% to $1.5B and operating income expanding 15.3% to $431.1M, indicating healthy operating leverage. Cash generation improved substantially with operating cash flow reaching $366.2M, while cash and equivalents grew notably to $146.7M. The balance sheet expanded proportionally with total assets reaching $2.2B and stockholders' equity growing to $1.2B, though current liabilities also increased to $472.9M as the company scales operations.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
+60.6%
$91.3M→$146.7M

Cash position surged 60.6% — strong cash generation or capital raise providing significant financial cushion.

Operating Cash Flow
Cash Flow
+57.3%
$232.7M→$366.2M

Operating cash flow surged 57.3% — exceptional cash generation, highest quality earnings signal.

Current Assets
Balance Sheet
+40%
$227.3M→$318.3M

Current assets grew 40% — improving short-term liquidity or inventory/receivables build.

Current Liabilities
Balance Sheet
+28.5%
$367.9M→$472.9M

Current liabilities rose 28.5% — increased short-term obligations, watch current ratio.

Interest Expense
P&L
+27.8%
$16.4M→$21.0M

Interest costs rose 27.8% — monitor debt levels and coverage ratio in rising rate environment.

Total Debt
Balance Sheet
+23.9%
$59.0M→$73.1M

Debt rose 23.9% — additional borrowing for investment or operations; monitor coverage ratios.

Stockholders Equity
Balance Sheet
+23.8%
$959.5M→$1.2B

Equity base grew 23.8% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Revenue
P&L
+19.5%
$1.2B→$1.5B

Revenue growing 19.5% — solid top-line momentum, watch margins for quality of growth.

Total Assets
Balance Sheet
+18.5%
$1.9B→$2.2B

Asset base grew 18.5% — expansion through organic growth, acquisitions, or capital deployment.

Operating Income
P&L
+15.3%
$374.0M→$431.1M

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

LANGUAGE CHANGES
NEW — 2026-02-19
PRIOR — 2025-02-20
ADDED
Management's Discussion and Analysis of Financial Condition and Results of Operations 31 Item 7A.
Collectively, we have approximately 497,700 students enrolled at five institutions with over 50 campuses as of December 31, 2025.
QS Stars , Gu a Universitaria (UVM), MERCO 2025 Institutional Reputation Ranking (UPC) 5 Our institutions in Mexico and Peru offer traditional higher education students a private education alternative, with multiple brands and price points in each market and innovative programs and strong career-driven outcomes.
In Mexico, private education providers constitute approximately 39% of the total higher-education market (47% in states in which we have operations).
Throughout Mexico and Peru we operate 24 medical and nine dental schools.
+7 more — sign up free →
REMOVED
Management's Discussion and Analysis of Financial Condition and Results of Operations 33 Item 7A.
Collectively, we have approximately 472,000 students enrolled at five institutions with over 50 campuses as of December 31, 2024.
In Mexico, private education providers constitute 39% of the total higher-education market (46% in states in which we have operations).
Throughout Mexico and Peru we operate 23 medical and nine dental schools.
When opening a new campus or expanding existing facilities, we use best practices that we have developed over more than the past decade to cost-effectively expedite the opening and development of that location.
+7 more — sign up free →
MORE OPPORTUNITY SIGNALS
ABTHIGHAbbott announced a major strategic acquisition of Exact Sciences Corporation to ...
2026-02-20
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →